---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000048"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2023-01-03T23:59:59+00:00"
generated_at: "2026-06-20T20:55:45.491980+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Fulgent Genetics appoints Reggie Groves to board, cures Nasdaq audit committee deficiency

## Summary
- Reggie Groves appointed to Fulgent Board effective Jan 3, 2023; serves on Audit, Compensation, and Nominating/Governance committees.
- Appointment resolves non-compliance with Nasdaq Rule 5605 requiring three independent directors on Audit Committee (disclosed Nov 18, 2022).
- Groves brings 13 years at Medtronic and experience as CFO/COO at Stimwave, CEO at REVA Medical, and board service at AtriCure.
- Groves will receive standard compensation per Non-Employee Director Compensation Policy and entered indemnification agreement.

## SEC filing metadata
- accession: 0000950170-23-000048
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2023-01-03T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000095017023000048/0000950170-23-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000095017023000048/flgt-20230103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000048
- JSON: https://secwatch.observer/filing/0000950170-23-000048.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000048.txt

## Key facts
- Executive change
  Regina Groves was appointed as Director at Fulgent Genetics, Inc..
  - Action: appointed
  - Role: Director
  source text: On January 3, 2023, the Board of Directors (the “Board”) of the Fulgent Genetics, Inc. (the “Company”) appointed Ms. Regina (“Reggie”) Groves to serve as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1674930/000095017023000048/0000950170-23-000048-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.